MVAnews LETTER no 6, August 2003
NEWS INDEX
Diabetes across Øresund II
Medicon Valley Financing Guide
New application date for Medicon Valley PhD Programme
Participate in Biotech Forum Exhibition & Conference 2003
Scandinavia and Medicon Valley in the Spotlight
First Private Danish Phase 1 company established
Two Medicon Valley players in collaboration
Danish ViroGates and Missionpharma in collaboration
All Øresund University educations under "One Roof"
Fruitful collaboration between scientists and companies
MVA NEWS
Diabetes across Øresund II
18 September 2003, Lund, Sweden
Medicon Valley
Academy invites to the leading diabetes forum for discussing key
challenges for future diabetes treatment and research in Medicon
Valley. More
Information... (Swedish)
Medicon Valley Financing Guide
Few sponsorships and ads are available. The guide contains advices on how to obtain venture capital, as well as contact info and profiles on national and international investors. The guide will be published November 2003. More Information... (English)
New application date for Medicon Valley PhD Programme
Final date for receipt of applications: 1 October 2003
The Greater Copenhagen Authority (HUR) and Region Skåne hereby invite scientists from the Øresund region to participate in the Medicon Valley PhD Programme. More Information... (English)
Participate in Biotech Forum Exhibition & Conference 2003
Stockholm, 26 - 28 November 2003
With med.xpo
2003 more than 400 exhibitioners and 20,000 visitors
participating in Stockholm, Biotech Forum is the largest medical-
and biotech exhibition of Northern Europe. Be a part of this event
- at the Medicon Valley exhibition stand at Biotech Forum!
More
Information... (Danish)
MEDICON VALLEY NEWS
Scandinavia and Medicon Valley in the spotlight
New Scandinavia feature in the New Scientist - entitled "Building Biotech Bridges". Medicon Valley stands out as "one of the strongest and the only biotech cluster to actively pursue collaborations outside of national borders, when comparing with other European biotech clusters. More Information... (English)
First Private Danish Phase 1 Company Established
The first private Danish phase 1 trial company, PhaseOneTrials A/S, has been established at H:S Hvidovre Hospital. The company, offering clinical phase 1 and early phase 2 trials, will be up and running from January 2004. More Information... (Danish)
Two Medicon Valley players in
collaboration
Amarin Development, based in Malmö, has been engaged to provide
pharmaceutical formulation and manufacturing services for ACADIA
Pharmaceuticals, based in Copenhagen, Denmark and San Diego,
California. More
Information... (English)
Danish ViroGates and Missionpharma in collaboration
Danish ViroGates and Missionpharma collaborate on promoting ViroGates' prognostic HIV kit in Africa. The kit is based on the suPAR-method (suPAR = soluble urikinase receptor) developed by Jesper Eugen-Olsen from Hvidovre Hospital. More Information... (Danish)
All Øresund University Educations under "One Roof"
New Internet Portal representing all the university education opportunities in the Øresund region. The Øresund University launches the web site January 2004 giving information on higher education in the region. More Information... (Swedish)
Fruitful collaboration between scientists and companies
40% of the scientists from the Faculty of Science, Univeristy of Copenhagen, are engaged in collaboration with the private sector. More Information... (Danish)
EVENTS
Life Science Discovery Seminar / 28 August 2003
10% reduction for MVA members. What technology can do for research. Relevant for you, strategically responsible for medical/biomedical research projects in biotech, academia, hospitals, pharma and in the public sector. More Information... (English)
1st Nordic Venture Summit / 16-17 September 2003
10% reduction for MVA members. A platform where fast-growing accomplished entrepreneurs, key private equity and corporate investors and their advisors meet each other in an exclusive setting. More Information... (English)